DeDora Capital’s Celgene Corp CELG Stock Holding History

DeDora Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,031	Closed	-$202K	–	127
2019 Q3	$202K	Sell	2,031 -231	-10%	-$21.9K	0.14%	85
2019 Q2	$209K	Hold	2,262	–	–	0.15%	86
2019 Q1	$213K	Buy	+2,262	New	+$198K	0.16%	84
2018 Q3	–	Sell	-4,657	Closed	-$370K	–	95
2018 Q2	$370K	Buy	4,657 +417	+10%	+$34.6K	0.29%	67
2018 Q1	$378K	Buy	4,240 +458	+12%	+$44K	0.31%	63
2017 Q4	$395K	Buy	+3,782	New	+$427K	0.33%	56

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

DeDora Capital's CELG Position: Q4 2019 in Review

DeDora Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,031 shares — an estimated $202K sold.

DeDora Capital first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $395K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

DeDora Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
DeDora Capital sold 2,031 Celgene Corp shares in Q4 2019, an estimated $202K.
DeDora Capital first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
DeDora Capital's Celgene Corp position peaked at $395K in Q4 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on DeDora Capital's 13F filing for Q4 2019, filed 21 Feb 2020.